Symposia
- Date:
- Time: -
- Track: Clinical Practice
- CME/CE: 1.0
- Q & A: Chat
Moderator: Teresa M. DeLellis, PharmD, BCPS, BCGP Sponsored by the Pharmacists Section
The purpose of this symposium is to educate the audience and summarize the changes over the past year in pharmacotherapy. The speakers will examine information regarding newly approved medications, as well as clinical implications, including potential adverse effects, related to medication formulations. Learning Objectives: (1) communicate the indication for use, mechanism of action, pharmacokinetics, dosing, safety, and drug interactions for newly approved medications; (2) compare potential advantages and disadvantages of incorporating new medications into clinical practice; (3) explain the clinical implications, including adverse effects, of various medication formulations that are used in older adult patients; and (4) apply their knowledge of medication formulations to assess for clinical implications in older adults.
| Newly Approved Medications and Place in Therapy for Older Adults Anushka Tandon, PharmD, BCPS, BCACP |
| The Hidden Risks of Medication Formulations Leigh Ann Mike, PharmD, BCPS, BCGP |